Open an account

Accendra Health

ACH · NYSE

$0.2554+$0.0352 (+15.99%)TodayMarket closed ·
Prev close $0.2202

About ACH

Accendra Health, Inc. engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. The company is headquartered in Glen Allen, Virginia and currently employs 6,500 full-time employees. Its Patient Direct segment includes home healthcare divisions (Byram and Apria). The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies and is a provider of integrated home healthcare equipment and related services in the United States. The company offers a range of products and services for in-home care and delivery, including diabetes treatment, home respiratory therapy (including home oxygen and non-invasive ventilation services), and obstructive sleep apnea treatment (including continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services). Additionally, it supplies a wide range of other home medical equipment, patient care product lines including ostomy, wound care (including negative pressure wound therapy), urology, incontinence and other products and services.

Employees
6,500
Headquarters
Glen Allen, Virginia
Listed
Mar 17, 1980
Sector
Health Care
Industry
Health Care Providers & Services
Website
accendrahealth.com

ACH key statistics

Market cap
16.93M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
1.99M
Volume
4.32M
Open price
$0.22
High today
$0.2628
Low today
$0.216
52 Week high
$5.60
52 Week low
$0.2169

Accendra Health (ACH) at a glance

As of Oct 20, 2026, Accendra Health (ACH) shares are priced at $0.2554, giving the company a market cap of 16.93M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.216 and $0.2628. The current price is 18.2% above the day's low and 2.8% below its high.

Volume so far is 4.32M shares, above the average of 1.99M shares a day.

Over the past year Accendra Health has ranged from $0.2169 to $5.60, and now sits 1% of the way up that range.

Accendra Health met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q2 FY26 it reported -$0.19 per share against an estimate of -$0.0892.

The average analyst price target is $1.54, 504.1% above the current price, from 4 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

25%of 4 analyst ratings say Buy
  • Buy25.0%
  • Hold75.0%
  • Sell0.0%
Price target · 5 analystsAvg $1.54
Low
$1.31
Now
$0.2554
High
$1.84

ACH earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 5 of the last 8 quarters, by 17.9% on average.

  1. Q3 FY24: reported $0.42 per share against an estimate of $0.4174
  2. Q4 FY24: reported $0.55 per share against an estimate of $0.5246
  3. Q1 FY25: reported $0.23 per share against an estimate of $0.1972
  4. Q2 FY25: reported $0.26 per share against an estimate of $0.2774
  5. Q3 FY25: reported $0.25 per share against an estimate of $0.2343
  6. Q4 FY25: reported $0.21 per share against an estimate of $0.223
  7. Q1 FY26: reported -$0.04 per share against an estimate of -$0.1023
  8. Q2 FY26: reported -$0.19 per share against an estimate of -$0.0892

ACH news

  • Press releaseBusiness Wire

    Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard

  • Press releaseBusiness Wire

    Accendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company’s Next Chapter of Growth

  • Press releaseBusiness Wire

    Accendra Health Updates on Capital Allocation and CEO Succession Timing Plans

  • 12 Health Care Stocks Moving In Monday's Intraday Session

  • 12 Health Care Stocks Moving In Monday's Pre-Market Session

  • Press releaseBusiness Wire

    Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Value

  • Press releaseBusiness Wire

    Accendra Health Reports Second Quarter 2026 Financial Results

  • Press releaseBusiness Wire

    Accendra Health’s Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search

Similar companies

Companies in the same industry as Accendra Health

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.